ATSN-201 was given regenerative medicine advanced therapy designation to treat X-linked retinoschisis, for which there ...

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...

Capital, a next-generation life sciences venture capital firm co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner, today announced the launch of its newest platform.

New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food allergies like peanut and shellfish.

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common conditions, today announced the appointment of Jacob Elkins, M.D., as Chief Medical ...

and orphan drug designation by the EMA. Additional key data is to be presented at scientific conference early this year. Pfizer additionally has phase 3 investigational studies in gene therapies ...

The FDA granted regenerative medicine advanced therapy designation to ATSN-201, a gene therapy candidate for the treatment of ...

MELBOURNE, Australia and INDIANAPOLIS, IN, USA I April 16, 2025 I Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces ...